Drawing for ECG-AI

USPTO serial 98218815

ECG-AI

Reviewed by CopyMark Law Group

Reg. 7978292Status 700Registered
Filing date
Status date
Registration date
Oct 7, 2025
Examiner
FARRAG, SHERIF G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ECG-AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stacey J. Watson

Stacey J. Watson MARKERY LAW LLCP.O. BOX 84150GAITHERSBURG, MD 20883-4150United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for analyzing cardiac data using artificial intelligence; downloadable software for analyzing electrocardiogram (ECG) data and diagnosing cardiac conditions using artificial intelligence; downloadable computer programs featuring artificial intelligence-based algorithms for analyzing electrocardiogram (ECG) signal data; downloadable and recorded computer software using artificial intelligence for machine learning to support clinical data platforms for diagnostics in the fields of cardiology and electrophysiology; downloadable medical software for managing and assessing cardiac data using artificial intelligence; downloadable medical software for electrocardiogram (ECG) recording, monitoring, analysis, and management using artificial intelligence; downloadable and recorded computer software for use with mobile computer systems, smartphones, and peripheral devices, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; downloadable software for use with mobile computer systems, smartphones and peripheral devices, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, transmitting physiological health data and providing additional clinical information, including co-morbidities, medications, procedures, for patients with similar electrocardiogram (ECG) readings.ACTIVESep 28, 2023
042Providing an on-line non downloadable system using artificial intelligence for analyzing electrocardiographs and electrocardiograms in support of making clinical decisions in the medical field; technical analysis of medical, biological and physiological data generated using medical and electrocardiogram machinery, artificial intelligence, and computer science for the prevention, diagnosis and analysis of heart disease; Software as a service (SAAS) services featuring software utilizing algorithms and artificial intelligence for use in machine learning in the field of collecting, analyzing, storing, and transmitting heart sound and electrocardiogram (ECG) recordings of the human body for detection, diagnosis, prediction and prognosis of cardiovascular disease; Software as a service (SAAS) services featuring software for analyzing and presenting electrocardiogram (ECG) data by applying artificial intelligence-based algorithms to the data; Software as a service (SAAS) services featuring software for using artificial intelligence for cardiac disease management; Software as a service (SAAS) services featuring software for heart rhythm recording, monitoring, and analysis using artificial intelligence; Software as a service (SAAS) services featuring software for analyzing cardiac data using artificial intelligence; Software as a service (SAAS) services featuring software for analyzing electrocardiogram (ECG) data and diagnosing cardiac conditions using artificial intelligence; providing online non-downloadable software featuring artificial intelligence-based algorithms for analyzing electrocardiogram (ECG) signal data; providing temporary use of on-line non-downloadable cloud computing software for analysis, interpretation and automatic diagnosis of electrocardiogram exams using artificial intelligence; advanced product research in the field of artificial intelligence; Software as a Service (SaaS) services, namely, hosting software for use by others for developing, hosting, managing, and maintaining applications, software, web services, and websites, all for medical use in monitoring and analyzing patient physiological activity and in transmitting and storing physiological health data none of the foregoing specifically directed to cardiology, critical care, or the physical treatment of structural heart disease; Software as a Service (SaaS) services, namely, hosting software for use by others for developing, hosting, managing, and maintaining applications, software, web services, and websites, all for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; providing online non-downloadable software for medical use in monitoring, recording, and analyzing personal physiological activity, analyzing electrocardiogram (ECG) readings, and in transmitting physiological health data; research and development services in the field of artificial intelligence; research, design and development of computer programs and softwareACTIVESep 28, 2023
044Providing health information in the nature of electrocardiogram (ECG) and heart rate readings and biometric data; providing health information in the nature of electrocardiogram (ECG) and heart rate readings and biometric data by means of online software applicationsACTIVESep 28, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2025NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 7, 2025R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Oct 3, 2025NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 10, 2025CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Sep 10, 2025IUAAUSE AMENDMENT ACCEPTED—
Jul 2, 2025AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Jul 2, 2025IUAFUSE AMENDMENT FILED—
Jul 2, 2025EAAUTEAS AMENDMENT OF USE RECEIVED—
Jul 2, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 28, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 28, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 3, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 3, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 3, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Sep 2, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jun 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2024DOCKASSIGNED TO EXAMINER—
Oct 16, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 14, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance